Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase

Protein Science

Volumn 15, Issue 4, 2006, Pages 862-870

  Bemporad, Francesco ^a   Taddei, Niccolò ^a   Stefani, Massimo ^a   Chiti, Fabrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

2,2,2 trifluoroethanol; Aggregation mechanism; Aromatic aromatic interaction; Assembly; Molecular recognition; Phenylalanine

Indexed keywords

ACYLPHOSPHATASE; AMYLOID; AROMATIC COMPOUND; MUSCLE ENZYME; PHENYLALANINE; THIOFLAVINE; TYROSINE;

ARTICLE; BETA SHEET; HYDROPHOBICITY; KINETICS; MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION;

ACID ANHYDRIDE HYDROLASES; AMINO ACID SUBSTITUTION; AMYLOID; BIREFRINGENCE; CIRCULAR DICHROISM; CONGO RED; DATA INTERPRETATION, STATISTICAL; HUMANS; HYDROPHOBICITY; MUSCLES; PHASE TRANSITION; PHENYLALANINE; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES; TRIFLUOROETHANOL; TYROSINE;

EID: 33645510751     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.051915806     Document Type: Article

References (53)

1. Azriel, R. and Gazit, E. 2001. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J. Biol. Chem. 276: 34156-34161.
2. Calamai, M., Taddei, N., Stefani, M., Ramponi, G., and Chiti, F. 2003. Relative influence of hydrophobicity and net charge in the aggregation of two homologous proteins. Biochemistry 42: 15078-15083.
3. Chelli, R., Gervasio, F.L., Procacci, P., and Schettino, V. 2002. Stacking and T-shape competition in aromatic-aromatic amino acid interactions. J. Am. Chem. Soc. 124: 6133-6143.
4. Chiti, F., Taddei, N., White, P.M., Bucciantini, M., Magherini, F., Stefani, M., and Dobson, C.M. 1999a. Mutational analysis of acylphosphatase suggests the importance of topology and contact order in protein folding. Nat. Struct. Biol. 6: 1005-1009.
5. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., and Dobson, C.M. 1999b. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. 96: 3590-3594.
6. Chiti, F., Calamai, M., Taddei, N., Stefani, M., Ramponi, G., and Dobson, C.M. 2002a. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl. Acad. Sci. 99: 16419-16426.
7. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G., and Dobson, C.M. 2002b. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9: 137-143.
8. Chiti, F., Stefani, M., Taddei, N., Ramponi, G., and Dobson, C.M. 2003. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808.
9. Chou, P.Y. and Fasman, G.D. 1974. Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteins. Biochemistry 13: 211-222.
10. Ciani, B., Hutchinson, E.G., Sessions, R.B., and Woolfson, D.N. 2002. A designed system for assessing how sequence affects α to β conformational transitions in proteins. J. Biol. Chem. 277: 10150-10155.
11. Creighton, T.E. 1993. Physical interactions that determine the properties of proteins. In Proteins: Structure and molecular proteins (ed. T.E. Creighton), pp. 139-170. W.H. Freeman and Co., New York.
12. Dobson, C.M. 2004. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 15: 3-16.
13. Du, H.N., Tang, L., Luo, X.Y., Li, H.T., Hu, J., Zhou, J.W., and Hu, H.Y. 2003. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein. Biochemistry 42: 8870-8878.
14. DuBay, K.F., Pawar, A.P., Chiti, F., Zurdo, J., Dobson, C.M., and Vendruscolo, M. 2004. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J. Mol. Biol. 341: 1317-1326.
15. El-Agnaf, O.M. and Irvine, G.B. 2002. Aggregation and neurotoxicity of α-synuclein and related peptides. Biochem. Soc. Trans. 30: 559-565.
16. Fernandez-Escamilla, A.M., Rousseau, F., Schymkowitz, J., and Serrano, L. 2004. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22: 1240-1241.
17. Gazit, E. 2002. A possible role for p-stacking in the self-assembly of amyloid fibrils. FASEB J. 16: 77-83.
18. Giasson, B.I., Murray, I.V.J., Trojanovski, J.Q., and Lee, V.M.Y. 2001. A hydrophobic stretch of 12 residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276: 2380-2386.
19. Gill, S.C. and von Hippel, P.H. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182: 319-326.
20. Guijarro, J.I., Sunde, M., Jones, J.A., Campbell, I.D., and Dobson, C.M. 1998. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. 95: 4224-4228.
21. Jiménez, J.L., Guijarro, J.I., Orlova, E., Zurdo, J., Dobson, C.M., Sunde, M., and Saibil, H.R. 1999. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18: 815-821.
22. Kajava, A.V., Aebi, U., and Steven, A.C. 2005. The parallel superpleated β-structure as a model for amyloid fibrils of human amylin. J. Mol. Biol. 348: 247-252.
23. Kallberg, Y., Gustafsson, M., Persson, B., Thyberg, J., and Johansson, J. 2001. Prediction of amyloid fibril-forming proteins. J. Biol. Chem. 276: 12945-12950.
24. Klunk, W.E., Pettegrew, J.W., and Abraham, D.J. 1989. Quantitative evaluation of congo red binding to amyloid-like proteins with a β-plated sheet conformation. J. Hystochem. Cytochem. 37: 1273-1281.
25. LeVine III, H. 1995. Thioflavin T interaction with amyloid β-sheet structures. Amyloid: Int. J. Exp. Clin. Invest. 2: 1-6.
26. Lopez de la Paz, M. and Serrano, L. 2004. Sequence determinants of amyloid fibril formation. Proc. Natl. Acad. Sci. 101: 87-92.
27. Makin, O.S., Atkins, E., Sikorski, P., Johansson, J., and Serpell, L.C. 2005. Molecular basis for amyloid fibril formation and stability. Proc. Natl. Acad. Sci. 102: 315-320.
28. Modesti, A., Taddei, N., Bucciantini, M., Stefani, M., Colombini, B., Raugei, G., and Ramponi, G. 1995. Expression, purification, and characterization of acylphosphatase muscular isoenzyme as fusion protein with glutathione S-transferase. Protein Expr. Purif. 6: 799-805.
29. Monti, M., Garolla di Bard, B.L., Calloni, G., Chiti, F., Amoresano, A., Ramponi, G., and Pucci, P. 2004. The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process. J. Mol. Biol. 336: 253-262.
30. Nelson, R., Sawaya, M.R., Balbirnie, M., Madsen, A.O., Riekel, C., Grothe, R., and Eisenberg, D. 2005. Structure of the cross-β spine of amyloid-like fibrils. Nature 435: 773-778.
31. Pastore, A., Saudek, V., Ramponi, G., and Williams, R.J.P. 1992. Three-dimensional structure of acylphosphatase. Refinement and structural analysis. J. Mol. Biol. 224: 427-440.
32. Pawar, A.P., Dubay, K.F., Zurdo, J., Chiti, F., Vendruscolo, M., and Dobson, C.M. 2005. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 350: 379-392.
33. Petkova, A.T., Ishii, Y., Balbach, J.J., Antzukin, O.N., Leapman, R.D., Delaglio, F., and Tycko, R. 2002. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. 99: 16742-16747.
34. Porat, Y., Stepensky, A., Ding, F., Naider, F., and Gazit, E. 2003. Completely different amyloidogenic potential of nearly identical peptide fragments. Biopolymers 69: 161-164.
35. Porat, Y., Mazor, Y., Efrat, S., and Gazit, E. 2004. Inhibition of islet amyloid polypeptide fibril formation: A potential role for heteroaromatic interactions. Biochemistry 43: 14454-14462.
36. Ritter, C., Maddelein, M., Siemer, A.B., Lührs, T., Ernst, M., Meier, B.H., Saupe, S.J., and Riek, R. 2005. Correlation of structural elements and infectivity of the HET-s prion. Nature 435: 844-848.
37. Saiki, M., Honda, S., Kawasaki, K., Zhou, D., Kaito, A., Konakahara, T., and Morii, H. 2005. Higher-order molecular packing in amyloid-like fibrils constructed with linear arrangements of hydrophobic and hydrogen-bonding side-chains. J. Mol. Biol. 348: 983-998.
38. Stefani, M. and Dobson, C.M. 2003. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81: 678-699.
39. Stefani, M., Taddei, N., and Ramponi, G. 1997. Insights into acylphosphatase structure and catalytic mechanism. Cell. Mol. Life Sci. 53: 141-151.
40. Street, A.G. and Mayo, S.L. 1999. Intrinsic β-sheet propensities result from van der Waals interactions between side chains and the local backbone. Proc. Natl. Acad. Sci. 96: 9074-9076.
41. Sunde, M. and Blake, C.C.F. 1997. The structure ofamyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50: 123-159.
42. Tartaglia, G., Cavalli, A., Pellarin, P., and Caflisch, A. 2004. The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates. Protein Sci. 13: 1939-1941.
43. Tjernberg, L.O., Callaway, D.J.E., Tjernberg, A., Hahne, S., Lilliehook, C., Terenius, L., Thyberg, J., and Nordstedt, C. 1999. A molecular model of Alzheimer amyloid β-peptide fibril formation. J. Biol. Chem. 274: 12619-12625.
44. Tjernberg, L., Hosia, W., Bark, N., Thyberg, J., and Johansson, J. 2002. Charge attraction and β propensity are necessary for amyloid fibril formation from tetrapeptides. J. Biol. Chem. 277: 43243-43246.
45. Torok, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C.G., and Langen, R. 2002. Structural and dynamic features of Alzheimer's A β peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277: 40810-40815.
46. Tracz, S.M., Abedini, A., Driscoll, M., and Raleigh, D.P. 2004. Role of aromatic interactions in amyloid formation by peptides derived from human amylin. Biochemistry 43: 15901-15908.
47. Vendruscolo, M., Paci, E., Dobson, C.M., and Karplus, M. 2001. Three key residues form a critical contact network in a protein folding transition state. Nature 409: 641-645.
48. Villegas, V., Zurdo, J., Filimonov, V.V., Aviles, F.X., Dobson, C.M., and Serrano, L. 2000. Protein engineering as a strategy to avoid formation of amyloid fibrils. Protein Sci. 9: 1700-1708.
49. West, M.W., Wang, W., Patterson, J., Mancias, J.D., Beasley, J.R., and Hecht, M. 1999. De novo amyloid proteins from designed combinatorial libraries. Proc. Natl. Acad. Sci. 96: 11211-11216.
50. Williams, A.D., Portelius, E., Kheterpal, I., Guo, J.T., Cook, K.D., Xu, Y., and Wetzel, R. 2004. Mapping A β amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335: 833-842.
51. Wu, C., Lei, H., and Duan, Y. 2005. The role of Phe in the formation of well-ordered oligomers of amyloidogenic hexapeptide (NFGAIL) observed in molecular dynamics simulations with explicit solvent. Biophys. J. 88: 2897-2906.
52. Wurth, C., Guimard, N.K., and Hecht, M.H. 2002. Mutations that reduce aggregation of the Alzheimer's Aβ42 peptide: An unbiased search for the sequence determinants of Aβ amyloidogenesis. J. Mol. Biol. 319: 1279-1290.
53. Zanuy, D., Porat, Y., Gazit, E., and Nussinov, R. 2004. Peptide sequence and amyloid formation; molecular simulations and experimental study of a human islet amyloid polypeptide fragment and its analogs. Structure 12: 439-455.